Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
LeMaitre to Present at the Needham Virtual Healthcare Conference
12:59pm, Monday, 05'th Apr 2021
BURLINGTON, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 20th Annual Needham Virt
5 MedTech Growth Stocks Gaining Ground in 2021 Amid Pandemic
09:51am, Thursday, 25'th Mar 2021
Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.
Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think " Yes "
01:37pm, Monday, 22'nd Mar 2021
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
Dividend Champion And Contender Highlights: Week Of March 21
12:25pm, Sunday, 21'st Mar 2021
A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.
LeMaitre (LMAT) Stock Jumps 5.2%: Will It Continue to Soar?
07:57am, Thursday, 18'th Mar 2021
LeMaitre (LMAT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Week 9 MDA Breakout Stocks - March 2021: Short-Term Picks To Give You An Edge
07:20am, Sunday, 28'th Feb 2021
Week 9 MDA Breakout Stocks - March 2021: Short-Term Picks To Give You An Edge
LeMaitre Vascular's (LMAT) CEO George LeMaitre on Q4 2020 Results - Earnings Call Transcript
05:48am, Sunday, 28'th Feb 2021
LeMaitre Vascular's (LMAT) CEO George LeMaitre on Q4 2020 Results - Earnings Call Transcript
Recap: LeMaitre Vascular Q4 Earnings
05:15pm, Thursday, 25'th Feb 2021
Shares of LeMaitre Vascular (NASDAQ:LMAT) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 47.83% over the past year to $0.34, wh
LeMaitre Q4 2020 Financial Results
04:15pm, Thursday, 25'th Feb 2021
BURLINGTON, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2020 results and announced an $0.11/share quarterl
Healthcare: A Wide Choice Of Large And Well-Established Companies
02:41am, Friday, 19'th Feb 2021
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets
LeMaitre Vascular to Present at Upcoming Investor Conferences
04:40pm, Tuesday, 16'th Feb 2021
BURLINGTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in four upcoming investor conferences.
LeMaitre Vascular Will Announce Fourth Quarter 2020 Earnings Results on February 25, 2021
01:07pm, Wednesday, 27'th Jan 2021
BURLINGTON, Mass., Jan. 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2020 financial results on Thursday, February 25, 20
LeMaitre Vascular to Present at Upcoming Investor Conferences
06:03pm, Tuesday, 29'th Dec 2020
BURLINGTON, Mass., Dec. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in January.
Checking LeMaitre Vascular For Blocked Arteries
06:52am, Thursday, 17'th Dec 2020
The LeMaitre's corporate health partly depends on how much its sales reps can do to overcome current blocks, and how soon the pandemic ends.
LeMaitre: Widened Capital Structure, Acquisitions Drive Top-Line Growth
01:39pm, Saturday, 12'th Dec 2020
LeMaitre has posted a strong quarter compounded by successful acquisition activity YTD, with little OPEX tied into profits in Q3. Management has widened the capital structure to be more debt inclusive
